eCOA and Connected Devices: Power Real-Time, Patient-Centered Clinical Trials

Clinical trial sponsors and CROs face growing pressure to accelerate timelines, reduce patient burden, and comply with evolving regulatory expectations. A proven path forward—eCOA platforms integrated with connected devices—enables continuous, real-time data capture without relying solely on patient recall or frequent site visits.

From metabolic and CNS studies to autoimmune and rare diseases, these combined strategies are improving data quality, enhancing compliance, and driving faster, more reliable outcomes.

Download our Playbook to explore the technologies, real-world applications, and sponsor insights shaping the future of wearables in clinical research.

What You’ll Learn

Why real-time, device-based data is now a regulatory expectation—not a luxury

How YPrime integrates glucometers, sensors, and wearables into eCOA workflows (including Dexcom CGM and traditional BGM)

A real-world case study showing how one sponsor captured glucose data remotely in a rare disease clinical trial

The key benefits for patients, CROs, and sponsors, from fewer site visits, cleaner datasets, stronger participant engagement, and more.

The FDA’s 2024 guidance on Digital Health Technologies (DHTs) confirms that connected devices are essential tools for decentralized clinical trials and hybrid trials. Whether you’re running a rare disease trial with 15 patients or a global GLP-1 study, YPrime’s eCOA and connected device strategy enables consistent, high-quality data to power your clinical research.